BioSilicon™ is a platform technology capable of being used across a broad range of medical applications including orthopaedics, tissue culturing and tissue scaffolds, gene delivery, neural interfacing and specialised drug delivery. The market for the first and last are currently worth US$13 billion and US$50 billion per annum respectively.
- Forums
- ASX - By Stock
- PSD
- info
PSD
psivida limited
info
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.